Clinical Trial Update: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating retigabine immediate release as adjunctive therapy for partial-onset seizures in adults has completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Potiga (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2013-11-11